Leerink Partners analyst Mani Foroohar has reiterated their bearish stance on MRNA stock, giving a Sell rating on November 14.Don't Miss our ...
Wolfe Research downgraded Matson (MATX) to Peer Perform from Outperform. The firm cites valuation for the downgrade. Matson has materially ...
Matson downgraded at Wolfe Research, expecting demand risk from China tariffs and lower ocean rates after shares outperformed this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback